UNITED THERAPEUTICS Corp Annual Net Income (Loss) Attributable to Parent in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
UNITED THERAPEUTICS Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2021 to 2023.
  • UNITED THERAPEUTICS Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $309M, a 15.5% increase year-over-year.
  • UNITED THERAPEUTICS Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $1.11B, a 23.5% increase year-over-year.
  • UNITED THERAPEUTICS Corp annual Net Income (Loss) Attributable to Parent for 2023 was $985M, a 35.4% increase from 2022.
  • UNITED THERAPEUTICS Corp annual Net Income (Loss) Attributable to Parent for 2022 was $727M, a 52.9% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $985M +$258M +35.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-21
2022 $727M +$252M +52.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-21
2021 $476M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.